| Literature DB >> 27879409 |
Shana O Kelley1,2,3,4.
Abstract
Conventional approaches to bacterial identification and drug susceptibility testing typically rely on culture-based approaches that take 2 to 7 days to return results. The long turnaround times contribute to the spread of infectious disease, negative patient outcomes, and the misuse of antibiotics that can contribute to antibiotic resistance. To provide new solutions enabling faster bacterial analysis, a variety of approaches are under development that leverage single-cell analysis, microfluidic concentration and detection strategies, and ultrasensitive readout mechanisms. This review discusses recent advances in this area and the potential of new technologies to enable more effective management of infectious disease.Entities:
Keywords: clinical automation; lab-on-a-chip; microfluidics; microtechnology
Mesh:
Substances:
Year: 2016 PMID: 27879409 DOI: 10.1177/2211068216680207
Source DB: PubMed Journal: SLAS Technol ISSN: 2472-6303 Impact factor: 3.047